Azora Therapeutics

AZR
3.7508.31% ( -0.340 )
Trading: Nov 16, 11:21:49 (EDT)

Profile

About

Azora Therapeutics
Azora Therapeutics
AZR.US

Azora Therapeutics, Inc. operates as a biopharmaceutical company that develops small molecule new chemical entities for the treatment of autoimmune and inflammatory diseases. It offers treatment for dermatology and gastroenterology. The company's pipeline includes AT177, a colon-targeted aryl hydrocarbon receptor (AhR) agonist to enable localized activation with limited systemic exposure in development for ulcerative colitis.

Profile

Company Name
Azora Therapeutics, Inc.
Market
NasdaqCM
Founded
Industry
--
Fiscal Year End
--

Related Securities

Industry

Management